A Clinical Approach to Multimodality Imaging in Pulmonary Hypertension

• Published in: Frontiers in cardiovascular medicine 2022-01, Vol.8, p.794706-794706
• Main Authors: Farrell, Christine, Balasubramanian, Aparna, Hays, Allison G, Hsu, Steven, Rowe, Steven, Zimmerman, Stefan L, Hassoun, Paul M, Mathai, Stephen C, Mukherjee, Monica
• Format: Article
• Language: English
• Subjects: Cardiovascular Medicine; computed tomography; echocardiography; magnetic resonance imaging; pulmonary hypertension; scintigraphy
• ISSN: 2297-055X; 2297-055X
• DOI: 10.3389/fcvm.2021.794706

Pulmonary hypertension (PH) is a clinical condition characterized by progressive elevations in mean pulmonary artery pressures and right ventricular dysfunction, associated with significant morbidity and mortality. For resting PH to develop, ~50-70% of the pulmonary vasculature must be affected, suggesting that even mild hemodynamic abnormalities are representative of advanced pulmonary vascular disease. The definitive diagnosis of PH is based upon hemodynamics measured by right heart catheterization; however this is an invasive and resource intense study. Early identification of pulmonary vascular disease offers the opportunity to improve outcomes by instituting therapies that slow, reverse, or potentially prevent this devastating disease. Multimodality imaging, including non-invasive modalities such as echocardiography, computed tomography, ventilation perfusion scans, and cardiac magnetic resonance imaging, has emerged as an integral tool for screening, classifying, prognosticating, and monitoring response to therapy in PH. Additionally, novel imaging modalities such as echocardiographic strain imaging, 3D echocardiography, dual energy CT, FDG-PET, and 4D flow MRI are actively being investigated to assess the severity of right ventricular dysfunction in PH. In this review, we will describe the utility and clinical application of multimodality imaging techniques across PH subtypes as it pertains to screening and monitoring of PH.